NDC 65162-455

Levomilnacipran

Levomilnacipran

Levomilnacipran is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Llc. The primary component is Levomilnacipran Hydrochloride.

Product ID65162-455_32f4b2b4-c912-43a2-8c5b-e370352b980d
NDC65162-455
Product TypeHuman Prescription Drug
Proprietary NameLevomilnacipran
Generic NameLevomilnacipran
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date2019-02-04
Marketing CategoryANDA / ANDA
Application NumberANDA210790
Labeler NameAmneal Pharmaceuticals LLC
Substance NameLEVOMILNACIPRAN HYDROCHLORIDE
Active Ingredient Strength120 mg/1
Pharm ClassesNorepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 65162-455-03

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-455-03)
Marketing Start Date2019-02-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65162-455-03 [65162045503]

Levomilnacipran CAPSULE, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA210790
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-04

Drug Details

Active Ingredients

IngredientStrength
LEVOMILNACIPRAN HYDROCHLORIDE120 mg/1

OpenFDA Data

SPL SET ID:bcbc5d92-e022-4a0d-ab4d-2b0d7aa68c58
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1433227
  • 1433233
  • 1433239
  • 1433217
  • UPC Code
  • 0365162437034
  • 0365162960037
  • 0365162455038
  • 0365162411034
  • Pharmacological Class

    • Norepinephrine Uptake Inhibitors [MoA]
    • Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    • Serotonin Uptake Inhibitors [MoA]
    • Norepinephrine Uptake Inhibitors [MoA]
    • Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    • Serotonin Uptake Inhibitors [MoA]

    NDC Crossover Matching brand name "Levomilnacipran" or generic name "Levomilnacipran"

    NDCBrand NameGeneric Name
    65162-411LevomilnacipranLevomilnacipran
    65162-437LevomilnacipranLevomilnacipran
    65162-455LevomilnacipranLevomilnacipran
    65162-960LevomilnacipranLevomilnacipran

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.